Scott R Gilbertson - JoVE Visualize

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

ACS Chemical Neuroscience|January 22, 2013

Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addictionKathryn A Cunningham, Noelle C Anastasio, Robert G Fox, et al.

Infection and Immunity|February 4, 2010

Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infectionScott T Moen, Carla A Blumentritt, Terry M Slater, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 25, 2013

Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behaviorNoelle C Anastasio, Scott R Gilbertson, Marcy J Bubar, et al.

Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

ACS Chemical Neuroscience|January 22, 2013

Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addictionKathryn A Cunningham, Noelle C Anastasio, Robert G Fox, et al.

Infection and Immunity|February 4, 2010

Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infectionScott T Moen, Carla A Blumentritt, Terry M Slater, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 25, 2013

Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behaviorNoelle C Anastasio, Scott R Gilbertson, Marcy J Bubar, et al.

Pageof 5